Medication Compliance in COPD Patients

Polański, Jacek; Chabowski, Mariusz; Świątoniowska-Lonc, Natalia; Mazur, Grzegorz; Jankowska‐Polańska, Beata

doi:10.1007/5584_2020_508

Cited by 12 publications

(8 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the Thi study, the poor adherence in the COPD group and asthma group accounted for 63.9% and 50%, respectively [ 21 ]. In the Polish study by Polański et al, only 14.15% of patients with COPD demonstrated high adherence to medications [ 22 ]. Asthma patients tended to express a higher sense of satisfaction with inhaler devices than COPD patients [ 21 ].…”

Section: Discussionmentioning

confidence: 99%

“…In the study by Nittala et al, male and low-income patients with asthma had more emergency room visits [ 27 ]. In their study, Polański et al found that economic inactivity had a significant adverse impact on adherence in patients with COPD [ 22 ]. Those patients who do not have a job (and thus have limited income) cannot afford to buy their medication, which has a negative impact on their adherence to treatment.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Treatment Adherence in Patients with Obstructive Pulmonary Diseases

Homętowska

Świątoniowska-Lonc²,

Klekowski

et al. 2022

IJERPH

Self Cite

View full text Add to dashboard Cite

COPD is the third most common cause of death globally. Adherence rates in patients with obstructive pulmonary diseases usually range between 10% and 40%. The aim of the study was to evaluate the level of treatment adherence to inhaled therapy in patients with obstructive pulmonary diseases. A total of 325 patients, of mean age 63.04 ± 11.29, with COPD or asthma, were included into the study between 2020 and 2021. The following questionnaires were used: Beliefs about Medicines Questionnaire, Test of Adherence to Inhalers and Adherence to Refills and Medications Scale. The respondents tended to be convinced of the necessity of their medication (3.87 points per question). The patients reported moderate levels of overall adherence (21.15 ± 6.23). A total of 74% of patients demonstrated sporadic non-compliance. We conclude that patients with obstructive pulmonary diseases are moderately adherent to their medication. Beliefs about medicines have a significant impact on adherence to medications. Being unemployed, being a non-smoker and belief in the necessity of medication are independent determinants of better medication adherence. The number of hospital admissions due to exacerbations of the disease over the last year and belief that medicines are harmful are independent determinants of poorer medication adherence.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Treatment Adherence in Patients with Obstructive Pulmonary Diseases

Homętowska

Świątoniowska-Lonc²,

Klekowski

et al. 2022

IJERPH

Self Cite

View full text Add to dashboard Cite

show abstract

“…Several studies have aimed to determine the association between different factors and treatment adherence in COPD patients, although the available evidence presents some limitations, such as the lack of a standardized definition of adherence, and the use of generic questionnaires (eg, Morisky-Green questionnaire) instead of inhaler-specific questionnaires like the Test of the Adherence to Inhalers (TAI). 17 , 18 Despite the mentioned limitations, the presence of comorbidities, particularly depression, smoking status, the dosing regimen, the complexity of the device, and patient’s self-awareness of the disease are the main factors that negatively impact in treatment adherence. Socioeconomic factors, such as the educational level and income status, have also demonstrated to negatively impact the adherence to inhaled therapy.…”

Section: Factors Associated With Decreased Adherence In Copdmentioning

confidence: 99%

Inhaler Adherence in COPD: A Crucial Step Towards the Correct

Turégano-Yedro,

Trillo-Calvo,

Navarro i Ros

et al. 2023

COPD

View full text Add to dashboard Cite

COPD is a typical example of chronic disease. As such, treatment adherence tends to be as low as between 30% and 50%, with specific issues in COPD due to the use of inhaled therapies. Decreased adherence in COPD is associated with worse outcomes, with increased risk for exacerbations and long-term mortality. Factors that impact adherence are multiple, some related to patient, some related to clinicians and finally some related to healthcare system. Among clinician factors, prescription of simplified treatment regimens delivered by an inhaler adapted to the patient’s characteristics is crucial. Although it has been observed a huge improvement in the design and usability of inhaler devices for COPD in the last two centuries, there is still a clear gap in this field. Smart inhalers as well as simplified treatment regimens could improve adherence and therefore improve long-term outcomes in COPD.

show abstract

“…Similarly, in the study by Scalone et al [29], patients in the GOLD D group were most adherent (81.2%) to treatment recommendations, while patients in the A group were least adherent (30.3%) at baseline, which was mainly attributed to overuse of inhaled corticosteroids in the less severe GOLD groups. On the other hand, Polanski et al [30] observed that low adherence to pharmacotherapy was determined by sociodemographic factors such as older age, female gender, loneliness, inactivity, and clinical factors -more frequent hospitalizations, sleep, and daily functioning disorders, higher severity of GOLD.…”

Section: Medication Adherence In Copdmentioning

confidence: 99%

Adherence to treatment recommendations of patients with chronic non-communicable respiratory diseases – a narrative review

Henryka¹

2023

J Educ Health Sport

View full text Add to dashboard Cite

Despite modern therapeutic solutions, patients with chronic obstructive pulmonary disease (COPD) and asthma do not achieve therapeutic benefits due to emerging obstacles to compliance. This review aimed to present and analyze the results of available studies evaluating the influence of sociodemographic, clinical, and psychosocial factors on the level of adherence of patients with COPD and asthma. This narrative review was based on papers indexed in the following databases: PubMed, MEDLINE, CINAHL, Web of Science, and Scopus. The analyzed studies showed that the adherence level of patients with COPD and asthma is unsatisfactory, ranging from 23.6 to 80%. The main factors increasing the level of adherence of COPD patients mentioned in the analyzed studies were: unemployment, taking LAMA, not smoking cigarettes, belief that medication is necessary, higher education, use of multi-dose DPI and MDI inhalers, a greater sense of self-efficacy, and longer duration of disease. Independent determinants of good adherence of patients with asthma were better quality of life, high level of disease control, treatment with ICS + LABA or FF/UMEC/VI, good knowledge about asthma, and positive attitude towards the disease. According to available studies, determinants lowering adherence among patients with COPD were overweight or obesity, depression, poor quality of life, belief that treatment is harmful, frequent hospitalizations, lack of knowledge about the disease and treatment, sleep disorders, and use of ICS, LABA/ICS. Patients with asthma who received infrequent functional support consumed alcohol and were convinced of the harm and lack of need for treatment were non-adherent. In addition, an association was shown between high levels of adherence and a reduction in ED visits and hospitalizations in asthma and COPD patients.

show abstract

Medication Compliance in COPD Patients

Cited by 12 publications

References 25 publications

Treatment Adherence in Patients with Obstructive Pulmonary Diseases

Treatment Adherence in Patients with Obstructive Pulmonary Diseases

Inhaler Adherence in COPD: A Crucial Step Towards the Correct

Adherence to treatment recommendations of patients with chronic non-communicable respiratory diseases – a narrative review

Contact Info

Product

Resources

About